The future of MDR research is promising, with ongoing efforts focused on understanding the molecular basis of resistance, developing novel therapeutic agents, and designing innovative delivery systems. Emerging technologies, such as CRISPR gene editing and artificial intelligence, are expected to accelerate the discovery of new targets and predictive models for MDR. Continued collaboration between researchers, clinicians, and pharmaceutical companies will be essential to translating these advances into effective clinical solutions.
